Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1700 of 2228 entries
View as:

Comparative Effectiveness of Empagliflozin in the US

Phase: N/A Priority: Normal
NCT ID: NCT03363464 Org: User:
Start: 10/16/17 End: 12/31/25 Due: 12/31/26

Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00096616 Org: User:
Start: 11/30/04 End: - Due: -

Dose Escalation Study of Continuous Once-daily Oral Treatment With BIBW 2992 in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02171728 Org: User:
Start: 11/30/04 End: - Due: -

Effectiveness and Handling of Spiolto® Respimat ® in COPD Patients - Italy

Phase: N/A Priority: Normal
NCT ID: NCT03003494 Org: User:
Start: 06/06/17 End: 07/30/18 Due: 07/30/19

A Study in Healthy People to Compare Two Different Tablets of BI 685509 and to Test How Food and Esomeprazole Influence the Amount of BI 685509 in the Blood

Phase: N/A Priority: Normal
NCT ID: NCT06193811 Org: User:
Start: 01/16/24 End: 03/14/24 Due: 03/14/25

A Study to Compare Meloxicam IM Once Daily Versus Meloxicam Orally Once Daily in Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00239382 Org: User:
Start: 07/01/04 End: 12/31/04 Due: 12/31/05

Pivotal Study in Advanced Parkinsons Disease Patients

Phase: N/A Priority: Normal
NCT ID: NCT00466167 Org: User:
Start: 04/30/07 End: - Due: -

Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease II

Phase: N/A Priority: Normal
NCT ID: NCT00796653 Org: User:
Start: 01/31/09 End: - Due: -

Study to Assess the Safety of Ipratropium Bromide, in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT02236182 Org: User:
Start: 07/31/98 End: - Due: -

Comprehensive Add on Study in Japan

Phase: N/A Priority: Normal
NCT ID: NCT01204294 Org: User:
Start: 09/30/10 End: 01/31/12 Due: 01/31/13

Natural History of Netherton Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT05902663 Org: User:
Start: 10/09/24 End: 03/31/25 Due: 03/31/26

A Study to Test Whether Different Combinations of BI 765063, Ezabenlimab, Chemotherapy, Cetuximab, and BI 836880 Help People With Head and Neck Cancer or Liver Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05249426 Org: User:
Start: 04/12/22 End: 07/31/26 Due: 07/31/27

A Study to Assess Safety, Tolerability and Pharmacokinetics of Single Rising Inhaled Doses of BI 1744 CL in Healthy Male and Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02171780 Org: User:
Start: 02/28/05 End: - Due: -

Pramipexole in Untreated and Levodopa-treated Parkinson's Disease Patients

Phase: N/A Priority: Normal
NCT ID: NCT02177357 Org: User:
Start: 11/30/98 End: - Due: -

Safety and Efficacy of Empagliflozin (BI 10773) and Sitagliptin Versus Placebo Over 76 Weeks in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01289990 Org: User:
Start: 02/28/11 End: 05/31/13 Due: 05/31/14

Evaluation of the Safety, Efficacy and Pharmacokinetics of MICARDIS® (Telmisartan) in Children and Adolescents With Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT02242344 Org: User:
Start: 04/30/06 End: - Due: -

Cross-Sectional Study: Prevalence of Restless Legs Syndrome in Patients With Unpleasant Sensations of the Legs

Phase: N/A Priority: Normal
NCT ID: NCT00557258 Org: User:
Start: 11/30/07 End: - Due: -

Multiple Rising Dose Study of BI 144807 Powder in Bottle in Mild Asthmatic Patients

Phase: N/A Priority: Normal
NCT ID: NCT01651598 Org: User:
Start: 07/31/12 End: 01/31/13 Due: 01/31/14

A Study to Examine Past Estimated Glomerular Filtration Rate (eGFR) Slope as a Risk Marker for Rapid Kidney Function Decline in People With Chronic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT04881448 Org: User:
Start: 09/16/21 End: 07/15/22 Due: 07/15/23

Effect of Spiriva® on Health-related Quality of Life in Chronic Obstructive Pulmonary Disease (COPD) Patients Who Stopped Smoking During Treatment.

Phase: N/A Priority: Normal
NCT ID: NCT02172547 Org: User:
Start: 04/30/06 End: - Due: -

Safety, Tolerability and Pharmacokinetics of BIBW 2948 BS in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02214901 Org: User:
Start: 03/31/05 End: - Due: -

Tolerability and Pharmacokinetics of BIIB 722 CL Drinking Solution and of BIIB 722 CL Filmcoated Tablet in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02227030 Org: User:
Start: 04/30/00 End: - Due: -

Influence of Food on the Bioavailability of Telmisartan/Amlodipine Fixed Dose Combination in Healthy Japanese Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02261064 Org: User:
Start: 12/31/08 End: - Due: -

This Study in Patients With Chronic Lymphocytic Leukaemia is Done to Determine a Safe and Effective Dose of BI 836826 in Combination With Venetoclax

Phase: N/A Priority: Normal
NCT ID: NCT03343678 Org: User:
Start: 01/17/18 End: 11/25/20 Due: 11/25/21

Respimat® Inhaler vs a Metered Dose Inhaler Using Berodual® in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT02176200 Org: User:
Start: 04/30/03 End: - Due: -